α,β-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages

American Journal of Respiratory Cell and Molecular Biology

Volumn 37, Issue 5, 2007, Pages 617-623

  Facchinetti, Fabrizio ^a   Amadei, Francesco ^a   Geppetti, Pierangelo ^b   Tarantini, Francesca ^b   Di Serio, Claudia ^b   Dragotto, Alberto ^b   Gigli, Paolo M ^b   Catinella, Silvia ^a   Civelli, Maurizio ^a   Patacchini, Riccardo ^a  

^a CHIESI FARMACEUTICI S P A   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chronic obstructive pulmonary disease; IL 8; THP 1 cells; TNF ; U937 cells

Indexed keywords

4 HYDROXYNONENAL; ACETALDEHYDE; ACETYLCYSTEINE; ACROLEIN; ALDEHYDE; CIGARETTE SMOKE; CROTONALDEHYDE; GLUTATHIONE ETHYL ESTER; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MASS SPECTROMETRY; MEDIATOR RELEASE;

ALDEHYDES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MACROPHAGES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 35848940292     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0130OC     Document Type: Article

References (47)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-280.
2. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515-548.
3. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-266. (discussion 290-291).
4. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S29-S32.
5. Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD 2004;1:59-70.
6. Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-854.
7. Culpitt SV, Rogers DF, Fenwick PS, Shah P. De Matos C, Russell RE, Barnes PJ, Donnelly LE. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003;58:942-946.
8. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996;9:1989-1994.
9. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998;12:380-386.
10. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170:492-498.
11. D'Hulst AI, Bracke KR, Maes T, De Bleecker JL, Pauwels RA, Joos GF, Brusselle GG. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006;28:102-112.
12. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chem Rev 1968;68:153-207.
13. MacNee W. Oxidants/antioxidants and copd. Chest 2000;117:303S-317S.
14. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 1996;21:669-681.
15. Huber GL, First MW, Grubner O. Marijuana and tobacco smoke gas-phase cytotoxins. Pharmacol Biochem Behav 1991;40:629-636.
16. Witscht H. Carcinogenic activity of cigarette smoke gas phase and its modulation by beta-carotene and n-acetylcysteine. Toxicol Sci 2005;84:81-87.
17. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:24-31.
18. Demirjian L, Abboud RT, Li H, Duronio V. Acute effect of cigarette smoke on tnf-alpha release by macrophages mediated through the erk1/2 pathway. Biochim Biophys Acta 2006;1762:592-597.
19. Raza MW, Essery SD, Weir DM, Ogilvie MM, Elton RA, Blackwell CC. Infection with respiratory syncytial virus and water-soluble components of cigarette smoke alter production of tumour necrosis factor alpha and nitric oxide by human blood monocytes. FEMS Immunol Med Microbiol 1999;24:387-394.
20. Walters MJ, Paul-Clark MJ, McMaster SK, Ito K, Adcock IM, Mitchell JA. Cigarette smoke activates human monocytes by an oxidant-ap-1 signaling pathway: Implications for steroid resistance. Mol Pharmacol 2005;68:1343-1353.
21. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006;291:L46-L57.
22. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, Nijkamp FP, Folkerts G. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 2006;7:66.
23. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997;155:1770-1776.
24. Phillips J, Kluss B, Richter A, Massey E. Exposure of bronchial epithelial cells to whole cigarette smoke: Assessment of cellular responses. Altern Lab Anim 2005;33:239-248.
25. Masubuchi T, Koyama S, Sato E, Takamizawa A, Kubo K, Sekiguchi M, Nagai S, Izumi T. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Pathol 1998;153:1903-1912.
26. Ouyang Y, Virasch N. Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 2000;106:280-287.
27. Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 2004;173:4164-4170.
28. Lambert C, McCue J, Portas M, Ouyang Y, Li J, Rosano TG, Lazis A, Freed BM. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 2005;116:916-922.
29. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286S-291S.
30. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14:336-363.
31. Caron E, Liautard JP, Kohler S. Differentiated u937 cells exhibit increased bactericidal activity upon lps activation and discriminate between virulent and avirulent listeria and brucella species. J Leukoc Biol 1994;56:174-181.
32. Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, Hamakubo T, Kodama T. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb 2004;11:88-97.
33. Dauber JH, Rossman MD, Daniele RP. Bronchoalveolar cell populations in acute sarcoidosis: observations in smoking and nonsmoking patients. J Lab Clin Med 1979;94:862-871.
34. Wirtz HR, Schmidt M. Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type ii cells in culture. Eur Respir J 1996;9:24-32.
35. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203-210.
36. Aldini G, Dalle-Donne I, Facino RM, Milzani A, Carini M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev 2006;7:817-868.
37. Floriano-Sanchez E, Villanueva C, Medina-Campos ON, Rocha D, Sanchez-Gonzalez DJ, Cardenas-Rodriguez N, Pedraza-Chaverri J. Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungs. Free Radic Res 2006;40:523-533.
38. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004;200:689-695.
39. Nordskog BK, Fields WR, Hellmann GM. Kinetic analysis of cytokine response to cigarette smoke condensate by human endothelial and monocytic cells. Toxicology 2005;212:87-97.
40. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 2002;1:291-315.
41. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
42. Schaur RJ, Dussing G, Kink E, Schauenstein E, Posch W, Kukovetz E, Egger G. The lipid peroxidation product 4-hydroxynonenal is formed by-and is able to attract-rat neutrophils in vivo. Free Radic Res 1994;20:365-373.
43. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999;274:2234-2242.
44. Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 2003;123:1054-1059.
45. Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Fabbri LM, Saetta M. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995;152:1262-1267.
46. Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci 2000;57:6-15.
47. Baxter A, Brough S, Cooper A, Floettmann E, Foster S, Harding C, Kettle J, McInally T, Martin C, Mobbs M, et al. Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg Med Chem Lett 2004;14:2817-2822.